Durvalumab: an investigational anti-PD-L1 monoclonal...

Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma

Faiena, Izak, Cummings, Amy L, Crosetti, Anna M, Pantuck, Allan J, Chamie, Karim, Drakaki, Alexandra
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 12
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S141491
Date:
January, 2018
File:
PDF, 724 KB
english, 2018
Conversion to is in progress
Conversion to is failed